Active, Not Recruiting
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
NCT01873326
- Conditions
- Germ Cell Tumors, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Chicago Chicago, Illinois, United States
- Mayo Clinic Rochester, Minnesota, United States